Dr Ferras Alwan

Dr Ferras Alwan

Consultant Haematologist

Haematology Video consultations available
£220self-pay fee
Book Now

About Dr Ferras Alwan

Dr Alwan specialises in bleeding disorders and thrombosis through his NHS practice at Imperial College NHS Trust, where he serves as Head of Service for Haemostasis and Thrombosis and directs the Imperial Haemophilia Comprehensive Care Centre. He is primarily an NHS-based consultant with his practice location listed as Fortius Clinic London.

Qualifications: MBBS BMedSci(Hons) MRCP FRCPath PhD

Recent and current appointments

  • Consultant Haematologist - Imperial College Healthcare Trust
  • Centre Director - Imperial Haemophilia Comprehensive Care Centre

Publications, lectures and teaching

  • Alwan F, Vendramin C, Liesner R, et al. Characterization and treatment of congenital thrombotic thrombocytopenic purpura, Blood
  • Alwan F, Vendramin C, Vanhoorelbeke K, et al. Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura, Blood
  • Underwood M, Alwan F, et al. Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura, J Thromb Haemost
  • Alwan F, Vendramin C, Budde U, et al. Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura, eJHaem
  • Alwan F, Mahdi D, Tayabali S et al. Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura, British Journal of Haematology
  • Arulkumaran N, Thomas M, Brealey, D et al. Plasma exchange for COVID‐19 thrombo‐inflammatory disease, eJHaem
  • Westwood J-P, Thomas M, Alwan F, et al. Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens, Blood Advances
  • Vendramin C, McGuckin S, Alwan F, et al. A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy, Transfusion
  • Alwan F, He A, Montoto S, et al. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy, AIDS

Conditions treated

As listed by Fortius Clinic

  • Deep vein thrombosis and pulmonary embolism
  • Thrombophilias
  • Haemophilia and rare bleeding disorders
  • Thrombotic Thrombocytopenic Purpura
  • Low platelets

Accepted insurers

Bupa ✓
AXA Health ✗
Vitality ✓
Aviva ✓
WPA ✗
Cigna ✓

Self-pay

Fixed consultation fee: £220

Clinics

Fortius Clinic London

66 Wigmore Street, London W1U 2SB

☎ 0203 195 2442

View clinic →

Fortius Clinic Marylebone

17 Fitzhardinge Street, London W1H 6EQ

☎ 0203 195 2442

View clinic →

Team

Consultants who work alongside Dr Ferras Alwan in the same specialty and clinics:

No other consultants share a clinic in this specialty.